Zmax Pediatric Vs Adult Concentration For The Treatment Of Acute Otitis Media

• Status: Completed
• Trial end date: 2006-12-01
• Target enrollment: 0
• Participant gender: All

Summary

Assess tolerability of different dosing formulations (adult versus pediatric).

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Pfizer

Criteria

Inclusion Criteria:

• Have clinical signs/symptoms of AOM in at least 1 ear

Exclusion Criteria:

• Known or suspected hypersensitivity, or intolerance to azithromycin or other macrolides or to any penicillin, beta-lactam antibiotic or beta lactamase inhibitor

• Previously diagnosed disease(s) of immune function

• Treatment with any systemic (intravenous, intramuscular, oral) antibiotic for any indication within 7 days prior to enrollment